Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance BLPH opened at $0.04 on Friday. The company has a market capitalization of $458,737.50, a PE ratio of -0.03 […]

Related Keywords

United States , ,Bellerophon Therapeutics Inc ,Renaissance Technologies ,Dimensional Fund Advisors ,Bellerophon Therapeutics Company Profile ,Securities Exchange Commission ,Geode Capital Management ,Bellerophon Therapeutics ,Free Report ,Get Free Report ,Exchange Commission ,Street Corp ,Fund Advisors ,Capital Management ,Bellerophon Therapeutics Daily ,Nasdaq Blph ,Blph ,Medical ,Initiated Coverage ,Stocknews Com ,